$TRUP

Qureshi Fawwad sold $183K of TRUP

Qureshi Fawwad (Chief Financial Officer) sold 6,111 shares of TRUPANION, INC. (TRUP) at $30.01 ($0.18M total) on 2026-08-26.

Original reporting
SEC EDGAR · Qureshi Fawwad
Published Aug 26, 2026, 10:56 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 26, 2026, 11:20 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TRUP
Neutral
high confidence
Mentioned
$TRUP
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRUPNeutralLow
01

Why it matters

The disclosed sale is modest and does not suggest significant insider sentiment shift.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

Potential upcoming earnings or product updates not reflected in this filing.

Relevance 4/10Novelty 4/10Timing: after-market 2026-08-26

Background

Form 4 filings disclose insider transactions; CFO sales are monitored for red flags.

Company-level read

Ticker impact

$TRUPNeutralHigh confidence
Context

CFO Qureshi Fawwad sold 6,111 shares at $30.01 each, total $183,391, reducing his holding to 4,230 shares.

Expected impact

minimal to none

Evidence & confidence

Sale amount is small relative to float and disclosed via Form 4, typical for insiders.

Market effects

None; Trupanion operates in pet insurance niche with limited sector ripple.

None; US-listed microcap with localized investor base.

Low

Counterpoint

If insider selling signals concerns, could be a weak bearish cue.

Key entities

  • Trupanion, Inc.

    US-listed pet insurance provider (NASDAQ: TRUP).

  • Qureshi Fawwad

    Chief Financial Officer of Trupanion.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TRUPMed

Why Trupanion (TRUP) Shares Are Sliding Today

Trupanion (TRUP) shares fell 5.8% after Piper Sandler downgraded the stock to Neutral, citing challenges in the pet insurance market and rising claim costs. The firm lowered its price target to $32 from $45. The stock has seen significant volatility, down 19.6% year-to-date and 35.6% from its 52-week high.

$TRUPHigh

Why is Trupanion stock sliding today?

Trupanion stock fell 6.4% after Piper Sandler downgraded it to Neutral and cut its price target to $32 from $45, citing revenue and margin pressures. Zacks Research also downgraded the stock, amplifying the selloff. The company's shares have retreated from their 52-week high of $46.98, trading near the 52-week low of $21.16.

$TRUPMed

Trupanion (TRUP) Is Up 13.4% After New Vet Partnerships and Q2 Results - Has The Bull Case Changed?

Trupanion reported Q2 2026 results with net income of $6.83 million and updated revenue guidance, and it announced new partnerships and integrations with Digitail and Home To Home. The article links VetDirect Pay and Exam Day coverage to pet-care workflows and discusses margin and subscription growth targets, including projected $2.0 billion revenue and $36.5 million earnings by 2029.

$METMed

Financial results round-up: MetLife, Prudential, Corebridge, Palomar, Heritage, TWFG, Root and more

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.

$TRUPMed

TRUPANION, INC. (TRUP): Results of Operations and Financial Condition

TRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Trupanion Reports Second Quarter 2026 Results Authorizes Share Repurchase Program SEATTLE, WA. August 5, 2026 -- Trupanion , Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the second quarter ended